Anuncia Medical, Inc. — Form D
Anuncia Medical, Inc. of Scottsdale, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-12. The offering totals $13.4M, of which $10.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-09-12
- Form: D
- Accession: 0001889938-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $13.4M
- Amount sold: $10.8M
- Remaining: $2.7M
- Investors: 66
- Date of first sale: 2024-08-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-523914
Issuer
- Name: Anuncia Medical, Inc.
- CIK: 0001889938
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 6908 E Thomas Rd., Scottsdale, AZ, 85251
- Phone: 978-942-5600
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Natalie D Stevens | Executive Officer | SCOTTSDALE, AZ |
| David Donabedian | Director | Lowell, MA |
| Richard Upton | Director | Lowell, MA |
| PJ Anand | Director | Lowell, MA |
| Stanton D Rowe | Director | SCOTTSDALE, AZ |
| Darryl D Baker | Executive Officer | SCOTTSDALE, AZ |
| Elsa Abruzzo | Director | SCOTTSDALE, AZ |
| Elsa Abruzzo | Executive Officer | SCOTTSDALE, AZ |
| Stephen D Oesterle | Director | SCOTTSDALE, AZ |
| Ghassan D Kassab | Director | SCOTTSDALE, AZ |
| Edgar D Janotta | Director | SCOTTSDALE, AZ |
Other filings by this issuer (8)
More